| Literature DB >> 24079262 |
Josh Hanson1, Sophia W K Lam, Shamsul Alam, Rajyabardhan Pattnaik, Kishore C Mahanta, Mahatab Uddin Hasan, Sanjib Mohanty, Saroj Mishra, Sophie Cohen, Nicholas Day, Nicholas White, Arjen Dondorp.
Abstract
BACKGROUND: Adults with severe malaria frequently require intravenous fluid therapy to restore their circulating volume. However, fluid must be delivered judiciously as both under- and over-hydration increase the risk of complications and, potentially, death. As most patients will be cared for in a resource-poor setting, management guidelines necessarily recommend that physical examination should guide fluid resuscitation. However, the reliability of this strategy is uncertain.Entities:
Mesh:
Year: 2013 PMID: 24079262 PMCID: PMC3851438 DOI: 10.1186/1475-2875-12-348
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Correlation between jugular venous pressure and invasive haemodynamic measures
| | ||||
|---|---|---|---|---|
| Very low JVP 4 | 68 | 566 (535 – 598) | 3.39 (3.24 – 3.54) | 10.5 (9.4 – 11.6) |
| Low JVP 5 | 50 | 519 (497–540) | 3.38 (3.21 – 3.55) | 9.6 (8.9 – 10.2) |
| Normal JVP 6 | 74 | 599 (570 – 629) | 3.58 (3.42 – 3.75) | 9.0 (8.5 – 9.5) |
| Elevated JVP 7 | 175 | 570 (553–588) | 3.46 (3.36 – 3.57) | 9.4 (9.0 – 9.8) |
1 Global end diastolic volume index (normal range 680–800 ml/m2).
2 Cardiac index (normal range 2.5-4.0 L/min/m2).
3 Extravascular Lung Water Index (normal range 3-7 ml/kg).
4 Not visible with the patient at 45º.
5 1 to 2 cm above the sternal angle with the patient at 45º.
6 3 to 4 cm above the sternal angle with the patient at 45º.
7 ≥5 cm above the sternal angle with the patient at 45º.
Ability of clinical signs to identify hypovolaemia in adults with severe malaria
| Dry mucous membranes | 235/324 | 42/65 | 85% | 21% | 73% | 35% |
| (80–89) | (14–29) | (68–78) | (24–48) | |||
| Dry axillae | 138/324 | 27/65 | 84% | 17% | 43% | 58% |
| (77–89) | (12–23) | (37–48) | (46–71) | |||
| Decreased tissue turgor | 12/324 | 7/65 | 63% | 16% | 4% | 89% |
| (38–84) | (12–20) | (2–6) | (79–96) | |||
| Prolonged capillary refill 2,3 | 28/307 | 1/53 | 97% | 16% | 9% | 98% |
| (82–100) | (12–20) | (6–13) | (90–100) | |||
| Tachycardia > 100 bpm3 | 127/308 | 16/53 | 89% | 17% | 41% | 70% |
| (82–93) | (12–23) | (36–47) | (56–82) | |||
| Tachycardia > 120 bpm3 | 28/308 | 2/53 | 93% | 15% | 9% | 96% |
| (78–99) | (12–20) | (6–13) | (87–100) | |||
| Low JVP4 | 101/303 | 18/64 | 85% | 18% | 33% | 72% |
| (77–91) | (14–24) | (28–39) | (59–82) |
PPV Positive predictive value, NPV Negative predictive value.
1 Hypovolaemic: global end diastolic volume index (GEDVI) <680 ml/m2, euvolaemic: GEDVI: 680–800 ml/m2.
2 Greater than 2 seconds.
3 Excluding patients receiving inotropic support.
4 JVP < 3-4 cm above the sternal angle with the patient at 45º.
Correlation between clinical signs of hypovolaemia and invasive haemodynamic measures
| | | ||||
|---|---|---|---|---|---|
| Mucous membranes | Normal | 132 | 572 (548 – 595) | 3.57 (3.43 – 3.71) | 9.6 (8.9 – 10.3) |
| Dry | 297 | 562 (548 – 576) | 3.42 (3.34 – 3.51) | 9.8 (9.4 – 10.1) | |
| Axillae | Moist | 253 | 571 (556–585) | 3.47 (3.38 -3.57) | 9.4 (9.0 -9.8) |
| Dry | 177 | 556 (536–576) | 3.46 (3.35 – 3.56) | 10.1 (9.6 -10.7) | |
| Tissue turgor | Normal | 409 | 560 (548 – 573) | 3.5 (3.43 - 3.57) | 9.7 (9.3- 10.0) |
| Decreased | 21 | 643 (602 – 684)ɸ | 2.83 (2.59 - 3.07) ɸ | 10.8 (9.3 – 12.2) | |
| Capillary return* | Normal | 371 | 566 (554–579) | 3.52 (3.45 -3.59) | 9.5 (9.2 – 9.9) |
| Reduced | 30 | 504 (473–534) ɸ | 2.84 (2.54 -3.14) ɸ | 9.9 (8.4 – 11.5) | |
| Heart rate* | <100 bpm | 269 | 575 (560 – 590) | 3.43 (3.36 – 3.51) | 9.3 (8.8 - 9.7) |
| ≥100 bpm | 150 | 543 (524 – 562) ɸ | 3.51 (3.38 – 3.65) | 10.0 (9.5 – 10.5) ɸ | |
| Heart rate* | <120 bpm | 387 | 565 (552 – 578) | 3.48 (3.41 – 3.55) | 9.4 (9.1 – 9.7) |
| ≥120 bpm | 32 | 528 (497 – 560) | 3.3 (2.93 - 3.66)Ʊ | 11.4 (10.2 - 12.7) ɸ |
1 Global end-diastolic volume index.
2 Cardiac index.
3 Extravascular lung water index.
* In the absence of inotropic therapy.
ɸ p < 0.01 for a difference.
Ʊ p < 0.05 for a difference.
Ability of clinical signs to identify volume responsiveness in adults with severe malaria (Includes only those patients receiving a fluid bolus of >500 ml in the absence of inotropic support)
| Dry mucous membranes | 19/23 | 44/58 | 30% (19–43) | 78% (52–94) | 83% (61–95) | 24% (14–37) |
| Dry axillae | 9/23 | 29/58 | 24% (11–40) | 67% (51–81) | 39% (20–61) | 50% (37–63) |
| Decreased tissue turgor | 2/23 | 2/58 | 50% (7–93) | 73% (61–82) | 9% (1–28) | 97% (88–100) |
| Prolonged capillary refill 1* | 4/23 | 12/57 | 25% (7–52) | 70% (58–81) | 17% (5–39) | 79% (66–89) |
| Tachycardia > 100 bpm | 11/23 | 29/58 | 28% (15–44) | 71% (54–84) | 48% (27–69) | 50% (37–63) |
| Tachycardia > 120 bpm | 0/23 | 3/58 | 0% (0–77) | 71% (59–80) | 0% (0–15) | 95% (86–99) |
| Low JVP2* | 11/23 | 15/57 | 42% (23–63) | 78% (64–88) | 48% (27–69) | 74% (60–85) |
| Very low JVP3* | 6/23 | 9/57 | 40% (16–68) | 74% (61–84) | 26% (10–48) | 84% (72–93) |
1 Greater than 2 seconds.
2 Low JVP: < 3–4 cm above the sternal angle with the patient at 45º.
3 Very low JVP: invisible at rest with the patient at 45º, jugular vein fills with base of neck compression.
* In one patient the JVP was not visible and in one the capillary refill was not recorded.
Ability of clinical signs to identify pulmonary oedema in adults with severe malaria
| Crepitations on auscultation | 30/99 | 46/254 | 39% (28–51) | 75% (70–80) | 39% (21–40) | 82% (77–86) |
| Tachypnoea >20 breaths/min | 81/98 | 221/250 | 27% (22–32) | 63% (48–77) | 83% (74–90) | 12% (8–16) |
| Tachypnoea >30 breaths/min | 38/98 | 71/250 | 35% (26–45) | 75% (69–80) | 39% (29–49) | 72% (66–77) |
| Elevated JVP1# | 47/92 | 121/247 | 28% (21–35) | 74% (66–80) | 51% (40–62) | 51% (45–57) |
| Low JVP2# | 31/92 | 69/247 | 31% (22–41) | 74% (68–80) | 34% (24–44) | 72% (66–78) |
PPV Positive predictive value, NPV Negative predictive value.
* Extravascular lung water index ≥ 11 ml/kg (patients with concomitant aspiration pneumonia excluded).
1 JVP ≥5 cm above the sternal angle with the patient at 45º.
2 JVP < 3–4 cm above the sternal angle with the patient at 45º.
# JVP not visible in all patients.